AzTrials
AzTrials

Acute Thoraco-Abdominal Emergency LesionsNCT07899931

Vision-Language-Based Large-Scale Model for Emergency Screening

A study testing powER vision-language large-model assisted CT reading and Conventional CT reading without AI assistance in people with Acute Thoraco-Abdominal Emergency Lesions, run by The First Hospital of Jilin University at 1 site in China.

Recruiting

Looking for participants now. Contact the study team or a site below to ask about taking part.

Sites and contacts
Official record
Search all trials

Trial summary

This is a single-center, prospective, stratified 1:1 parallel-group randomized superiority diagnostic trial at The First Hospital of Jilin University. Eligible emergency patients aged ≥18 who received routine thoraco-abdominal non-contrast CT were randomly assigned to two groups. Read more about this study

Who is it for?
Ages 18 years and older
What is being tested?
powER vision-language large-model assisted CT reading and Conventional CT reading without AI assistance
Could I receive a placebo?
No, everyone receives an active treatment
How many people
640 participants
Where
1 siteChina
Study dates
1 Sep 2026to 10 Nov 2026
Phase
Interventional
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • Adult patients aged 18 years or older presenting to emergency department requiring thoraco-abdominal CT examination for suspected acute intra-thoracic or intra-abdominal emergency conditions.
  • Clinically indicated emergency thoraco-abdominal CT scan ordered by emergency physicians.
  • Patient or legal representative provides written informed consent for participation in this prospective study.
  • Availability for clinical follow-up to establish reference-standard diagnosis.

Who cannot join

  • Age under 18 years old.
  • Contraindications for contrast-enhanced CT examination (severe contrast allergy, uncorrectable severe renal dysfunction).
  • Inability to complete CT acquisition according to protocol due to critical clinical instability.
  • Refusal to participate or inability to obtain valid informed consent.
  • Prisoners or vulnerable populations who are inappropriate for enrollment.

Trial locations and contacts

1 site in 1 country. Contact the study team or a site near you to ask about taking part.

Jiaqi Gong Gong, MBBS contact

+8615104483768

1223841862@qq.com

China1 site, 1 recruiting
  • The First Hospital of Jilin University

    Changchun, Jilin, 130021

    Jiaqi Gong, MBBS, +8615104483768, 1223841862@qq.com

    Recruiting

Other trials in China

About this study

Official title: Clinical Research Protocol for a Vision-Language-Based Large-Scale Model in Emergency Screening

This is a single-center, prospective, stratified 1:1 parallel-group randomized superiority diagnostic trial at The First Hospital of Jilin University. Eligible emergency patients aged ≥18 who received routine thoraco-abdominal non-contrast CT were randomly assigned to two groups. The experimental group adopted a self-developed vision-language large model (powER) for auxiliary CT interpretation, while the control group received standard radiological reading without AI assistance. All participants completed standardized 60-day clinical follow-up to obtain clinical gold-standard outcomes. The primary objective is to compare the diagnostic performance of the AI model versus conventional radiology interpretation for multiple acute thoraco-abdominal emergency lesions.

Read the detailed description

This single-center prospective randomized controlled trial adopted a parallel-group superiority design with a 1:1 allocation ratio. Randomization was performed via an independent central randomization system without stratification to avoid allocation bias. The trial is open-label for radiologists performing image interpretation, while outcome adjudicators and biostatisticians remain blinded to group assignment throughout analysis. Two study arms were set:

Experimental Arm: Radiologists interpreted thoraco-abdominal CT scans assisted by the powER vision-language foundation model. The model performs inference on input CT images and outputs ranked top 3 suspected critical lesions covering 18 categories of acute thoracic and abdominal emergencies, including aortic dissection, visceral lacerations, multiple fractures, acute pancreatitis, intestinal obstruction, etc.

Control Arm: The powER model also runs full background AI inference for every case and stores model outputs in the backend database, but no AI-generated lesion findings are displayed to the reading radiologists. Radiologists perform CT diagnosis on native PACS workstations relying solely on conventional clinical experience, with identical web interfaces as the experimental arm.

All eligible patients presented emergency-related clinical indications for thoraco-abdominal CT, with image quality meeting diagnostic standards. Pregnant women, patients with uncorrectable severe imaging artifacts, and those receiving only head or limb CT were excluded. All patient imaging and clinical data were fully de-identified for privacy protection.

The primary outcome measure was diagnostic decision-making time per case, defined as the time interval from the reporting radiologist opening the case on the web platform to the submission of diagnostic selections for target emergency lesions.

Secondary outcome measures included the ROC-AUC, sensitivity, specificity, PPV and NPV of lesion identification by reporting radiologists (using integrated clinical diagnosis, surgery and pathological results within 60-day follow-up as the reference gold standard), total report-writing turnaround time, report review turnaround time, radiologist diagnostic confidence score, and diagnostic consistency between reporting radiologists and the clinical reference standard (Kappa value).

Exploratory endpoints covered subgroup performance stratified by disease severity, identification capacity for rare emergency lesions, and auxiliary effects on radiologists with different seniority levels.

All participants signed written informed consent before enrollment. Standardized 60-day follow-up was implemented to record hospitalization duration, complications and all-cause 60-day mortality. Adverse events related to AI misdiagnosis or system failure were fully recorded and reported to the institutional ethics committee. All statistical analyses followed pre-specified statistical plans. The between-group comparison of the primary continuous time endpoint will use t-test or Mann-Whitney U test as appropriate. The DeLong test will be adopted for AUC comparison of secondary diagnostic outcomes, and mixed-effect regression models will be used for further adjusted analyses. The total planned enrollment will be determined based on the sample size calculation for the primary outcome of diagnostic decision-making time.

Being tested
powER vision-language large-model assisted CT reading, Conventional CT reading without AI assistance
Keywords
Artificial intelligence, Large language model, Emergency CT, Thoraco-abdominal diseases, Diagnostic performance

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • powER vision-language large-model assisted CT readingDiagnostic test

    Standard manual interpretation of emergency thoraco-abdominal CT by radiologists with AI model assistance.

  • Conventional CT reading without AI assistanceDiagnostic test

    Standard manual interpretation of emergency thoraco-abdominal CT by radiologists without AI model assistance.

Study groups in NCT07899931
Study groupRoleWhat they receive
powER vision-language large-model assisted CT readingExperimentalRadiologists interpret emergency thoraco-abdominal CT scans with auxiliary outputs generated by the powER vision-language large model. This AI system identifies suspected critical lesions and presents these findings as references to support radiological review. Radiologists retain the final diagnostic decision. All participants receive routine standard clinical management.
Receives: Diagnostic Test: powER vision-language large-model assisted CT reading
Conventional CT reading without AI assistanceActive comparatorRadiologists perform independent reading of emergency thoraco-abdominal CT on standard PACS workstation, without any AI auxiliary tools. Diagnosis relies solely on radiologists' conventional clinical experience.
Receives: Diagnostic Test: Conventional CT reading without AI assistance

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Per-case CT diagnostic decision time

    Time interval from opening the emergency thoraco-abdominal CT case on the reading platform to completion of critical lesion selection for diagnostic decision-making. This outcome compares the powER vision-language large-model assisted reading group with the conventional radiological reading group.

    Measured: Day 1 (at completion of CT image reading)

Secondary outcomes (1)
  1. Sensitivity for detecting critical emergency lesions on emergency thoraco-abdominal CT

    Sensitivity for detection of critical emergency lesions (including hemorrhage, visceral perforation, aortic dissection, etc.) on emergency thoraco-abdominal CT. The 60-day comprehensive clinical, surgical and pathological findings after randomization serve as the reference gold standard. This outcome compares powER vision-language large-model assisted radiological reading with conventional radiological reading.

    Measured: up to 60 days

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted28 Oct 2026
  2. Study start1 Sep 2026
  3. Primary completion31 Oct 2026 (estimated)
  4. Study completion10 Nov 2026 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Diagnosis
Allocation
Randomised
Intervention model
Parallel groups
Model description
1:1 parallel-group randomized controlled trial. Subjects are randomly assigned to the AI-assisted reading arm or conventional reading arm via an independent central randomization system.
Masking
Double blind
Who is masked
Participant, Outcomes assessor
Enrolment
640 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT07899931
Sponsor's protocol ID
25K505-001
Status last verified
Aug 2026
First submitted
15 Oct 2026
Last updated
28 Oct 2026
Results posted
No
Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Undecided: Individual-participant data will not be shared externally due to patient privacy protection requirements and local data-regulatory constraints. Aggregated study results will be published in peer-reviewed journals.

Questions about this trial

What is this clinical trial studying?

A study testing powER vision-language large-model assisted CT reading and Conventional CT reading without AI assistance in people with Acute Thoraco-Abdominal Emergency Lesions, run by The First Hospital of Jilin University at 1 site in China.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 4 inclusion and 5 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: looking for participants now, as of the sponsor's last update on 28 Oct 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in China. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

Contact Jiaqi Gong Gong, MBBS (+8615104483768, 1223841862@qq.com), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Per-case CT diagnostic decision time (time frame: Day 1 (at completion of CT image reading)). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 28 Oct 2026.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in